Seminar
“Nice In The USA?”
- Date:
- 30 Jun 06
- Speakers:
- Peter Neumann, Tufts University
- Outline
- Economic evaluation is little used in the USA. Health spending per capita is the highest in the world. The recent growth of “evidence based medicine” in the US is seen as a tool to cut costs and restrict choice rather than to improve quality.
- Full Description
- The new Medicare drug benefit for eldery people is widely expected to exceed its budget. Not surprisingly, there have been calls for a NICE type institution in the US – and fierce resistance to this. Peter Neumann from Tufts University (until recently at the Harvard University School of Public Health) is the foremost thinker on the use of (and lack of use of ) cost-effectiveness analysis in the US public and privately funded health care systems. Drawing on his New England Journal of Medicine paper and his recent book”Using Cost-effectiveness Analysis to Improve Healthcare: Opportunities and Barriers” he explained the barriers to the use of economic evaluation in the US and how its use is likely to evolve.